ZENTALIS PHARMACEUTICALS INC. - COMMON STOCK
3,2200
24-декабря-24 13:45:00
15 мин. задержка
Акции
+0,0400
+1,26%
Сегодняшний диапазон
3,1350 - 3,2600
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Zentalis Pharmaceuticals Announces Key Management Appointments
12 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 дек 2024 16:35:10 Источник Nasdaq GlobeNewswire
-
13 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 ноя 2024 19:04:44 Источник Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies
16 сен 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024
09 сен 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 сен 2024 16:40:50 Источник Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Progress
09 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 авг 2024 18:00:00 Источник Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 июл 2024 18:00:47 Источник Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program
18 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 июн 2024 18:00:55 Источник Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
30 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
29 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
23 май 2024 17:01:39 Источник Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit
14 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
07 май 2024 07:00:01 Источник Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 май 2024 17:30:00 Источник Nasdaq GlobeNewswire
-
02 апр 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 апр 2024 17:30:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >